Skip to content

Envoy Medical COCH Raw materials

Raw materials at other companies

Cabot Corporation logo
Cabot CorporationCBT
$144M-2.0%
Bioventus logo
BioventusBVS
$19.3M-15.5%
CorMedix logo
CorMedixCRMD
$6.22M+460%
SOL
SOLSSOLS
$62M
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$17.25M-52.3%
Silgan Holdings logo
Silgan HoldingsSLGN
$483.44M+9.7%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterials.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's raw materials?
Envoy Medical (COCH) reported raw materials of $1.24M in Q1 2026.
How has Envoy Medical's raw materials changed year-over-year?
Envoy Medical's raw materials decreased by 13.6% year-over-year, from $1.44M to $1.24M.
What is the long-term trend for Envoy Medical's raw materials?
Over 3 years (2022 to 2025), Envoy Medical's raw materials has grown at a 7.7% compound annual growth rate (CAGR), from $1.01M to $1.26M.